Drug interactions
Lemborexant + Liposomal doxorubicin
Severity: Minor
Lemborexant and Liposomal doxorubicin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Doxorubicin is not a recognized CYP3A4 inhibitor, so an increase in lemborexant exposure is unlikely. Both drugs can cause somnolence or fatigue in some patients, but a clear pharmacokinetic interaction is not established.
What this interaction means in plain words
Lemborexant and Liposomal doxorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Lemborexant belongs to Central Nervous System; Liposomal doxorubicin belongs to Oncology.
Why it happens
No established pharmacokinetic mechanism; any CYP3A4 inhibition by doxorubicin is theoretical.
What to do
Use the usual lemborexant dose and watch for next-day drowsiness. Reduce the dose if excessive sedation occurs.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Lemborexant and Liposomal doxorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Liposomal doxorubicin
- Dengue vaccine + Liposomal doxorubicin Contraindicated
- Belatacept + Liposomal doxorubicin Major
- Cyclosporine + Liposomal doxorubicin Major
- Dronedarone + Liposomal doxorubicin Major
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin Major
- Fingolimod + Liposomal doxorubicin Major
Other interactions of Lemborexant
Frequently asked questions
Can I take Lemborexant with Liposomal doxorubicin?
MediHelp rates the interaction as minor. Lemborexant and Liposomal doxorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Doxorubicin is not a recognized CYP3A4 inhibitor, so an increase in lemborexant exposure is unlikely. Both drugs can cause somnolence or fatigue in some patients, but a clear pharmacokinetic interaction is not established.
How serious is the interaction between Lemborexant and Liposomal doxorubicin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the usual lemborexant dose and watch for next-day drowsiness. Reduce the dose if excessive sedation occurs.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
